ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Morphic Holding Inc

Morphic Holding Inc (MORF)

56.99
0.00
( 0.00% )
Updated: 11:00:00

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
56.99
Bid
56.88
Offer
56.99
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
56.99
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

MORF Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

MORF - Frequently Asked Questions (FAQ)

What is the current Morphic share price?
The current share price of Morphic is US$ 56.99
What is the 1 year trading range for Morphic share price?
Morphic has traded in the range of US$ 0.00 to US$ 0.00 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
XHLDTEN Holdings Inc
US$ 1.19
(103.35%)
168.5M
LSELeishen Energy Holding Company Ltd
US$ 13.06
(68.08%)
14.28M
BOWNBowen Acquisition Corporation
US$ 6.50
(50.29%)
6.29M
WHLRLWheeler Real Estate Investment Trust Inc
US$ 262.87
(44.12%)
408
CSAICloudastructure Inc
US$ 7.63
(36.98%)
3.15M
WCTWellchange Holdings Company Limited
US$ 0.246
(-37.72%)
11.36M
ONVOOrganovo Holdings Inc
US$ 0.2579
(-36.15%)
2.96M
KBSXFST Corporation
US$ 3.99
(-27.32%)
4.1M
BHILBenson Hill Inc
US$ 0.5715
(-24.80%)
226.39k
BONBon Natural Life Ltd
US$ 0.3641
(-21.92%)
25.49M
XHLDTEN Holdings Inc
US$ 1.19
(103.35%)
168.5M
NVDANVIDIA Corporation
US$ 118.8602
(2.97%)
165.32M
SUNESUNation Energy Inc
US$ 0.5001
(27.90%)
115.5M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 8.0284
(7.48%)
108.75M
BDTXBlack Diamond Therapeutics Inc
US$ 2.06
(22.62%)
102.75M